131 related articles for article (PubMed ID: 5587721)
1. [Eye and skin complications with long-term treatment of psychopharmaceutic agents].
Gunby B
Nord Psykiatr Tidsskr; 1967; 21(5):378-88. PubMed ID: 5587721
[No Abstract] [Full Text] [Related]
2. Toxic effects of phenothiazines on the eye.
Boet DJ
Doc Ophthalmol; 1970 Jul; 28(1):1-69. PubMed ID: 5312274
[No Abstract] [Full Text] [Related]
3. Ocular complications related to phenothiazines.
Siddall JR
Dis Nerv Syst; 1968 Mar; 29(3):Suppl:10-3. PubMed ID: 4876740
[No Abstract] [Full Text] [Related]
4. Ocular (pigmentary) effects of psychotropic drugs.
Appleton WS; Shader RI; DiMascio A
Conn Med; 1970 Jan; 34(1):25-8. PubMed ID: 4903792
[No Abstract] [Full Text] [Related]
5. [The neuroleptic syndrome. Attempted systematization of primary and secondary effects observed during neuroleptic treatments].
Lambert PA
Encephale; 1971; 60(4):335-49. PubMed ID: 5004893
[No Abstract] [Full Text] [Related]
6. [Complications on the part of the eyes during employment of psychotropic drugs (review of the foreign literature)].
Gol'dovskaia IL
Zh Nevropatol Psikhiatr Im S S Korsakova; 1969; 69(6):935-9. PubMed ID: 4905472
[No Abstract] [Full Text] [Related]
7. Prolonged pharmacotherapy and the eye. A symposium. The antimalarials and the tranquilizers.
Rubin M
Dis Nerv Syst; 1968 Mar; 29(3):Suppl:67-76. PubMed ID: 4233735
[No Abstract] [Full Text] [Related]
8. Phenothiazine retinopathy.
Boet DJ
Ophthalmologica; 1969; 158 Suppl():574-82. PubMed ID: 5359756
[No Abstract] [Full Text] [Related]
9. Ocular effects of phenothiazine derivatives and reversibility.
Mathalone MB
Dis Nerv Syst; 1968 Mar; 29(3):Suppl:29-35. PubMed ID: 5672561
[No Abstract] [Full Text] [Related]
10. An adverse reaction unit: results and functions.
Ananth JV; Ban TA; Lehmann HE; Rizvi FA
Am J Psychiatry; 1971 Apr; 127(10):1339-44. PubMed ID: 5092571
[No Abstract] [Full Text] [Related]
11. [Ocular involvement during prolonged treatment with neuroleptics].
Nouri A; Cuendet JF
Schweiz Med Wochenschr; 1968 Oct; 98(43):1708-11. PubMed ID: 4974196
[No Abstract] [Full Text] [Related]
12. [Adverse effects of phenothiazines].
Roos BE
Nord Psykiatr Tidsskr; 1968; 22(2):97-100. PubMed ID: 5704635
[No Abstract] [Full Text] [Related]
13. [Ocular manifestations during treatment with phenothiazine derivatives].
Ardouin M; Feuvrier YM; Delattre A
Bull Soc Ophtalmol Fr; 1969 Mar; 69(3):395-401. PubMed ID: 5383905
[No Abstract] [Full Text] [Related]
14. Prognosis of eye complications caused by phenothiazines.
Forrest FM; Snow HL
Dis Nerv Syst; 1968 Mar; 29(3):Suppl:26-8. PubMed ID: 5672560
[No Abstract] [Full Text] [Related]
15. Eye changes in connection with neuroleptic treatment especially concerning phenothiazines and thioxanthenes.
Edler K; Gottfries CG; Haslund J; Ravn J
Acta Psychiatr Scand; 1971; 47(4):377-84. PubMed ID: 5146713
[No Abstract] [Full Text] [Related]
16. [Ultrastructural study of ocular pigmentation due to phenothiazines].
Sizaret P; Rossazza C; Brassart B
Rev Otoneuroophtalmol; 1975; 47(4):247-51. PubMed ID: 1215727
[No Abstract] [Full Text] [Related]
17. [Eye pigmentation disorders in patients treated with phenothiazines].
Sizaret P; Quéré M; Degiovanni E; Degiovanni A
Encephale; 1968; 57(6):515-24. PubMed ID: 5730657
[No Abstract] [Full Text] [Related]
18. Prolonged treatment of psychotic states. (Over 1600 patients treated continuously 3 to 7 years).
Goldman D
Dis Nerv Syst; 1968 Mar; 29(3):Suppl:51-7. PubMed ID: 4970486
[No Abstract] [Full Text] [Related]
19. LENS AND CORENEA CHANGES DURING PHENOTHIAZINE THERAPY: A PRELIMINARY REPORT.
BARSA JA; NEWTON JC; SAUNDERS JC
Am J Psychiatry; 1965 Sep; 122():331-2. PubMed ID: 14327480
[No Abstract] [Full Text] [Related]
20. Ocular complications of phenothiazines.
Mathalone MB
Trans Ophthalmol Soc U K (1962); 1966; 86():77-88. PubMed ID: 5226613
[No Abstract] [Full Text] [Related]
[Next] [New Search]
